NMDA RECEPTOR MODULATORS AND THEIR APPLICATION Russian patent published in 2017 - IPC C07K5/10 A61K38/07 A61P25/24 A61P25/28 A61P25/18 A61P25/22 

Abstract RU 2621049 C2

FIELD: pharmacy.

SUBSTANCE: compounds are intended for application in treatment of diseases and disorders such as cognitive diseases and disorders, cognitive activity and analgesia, particularly for neuropathic pain relief and/or reduction. .

EFFECT: enhanced efficiency of NMDA receptor activity modulation.

12 cl, 16 dwg, 4 tbl, 24 ex

Similar patents RU2621049C2

Title Year Author Number
PHARMACEUTICAL COMBINATION OF ATYPICAL ANTIPSYCHOTIC AND NMDA MODULATOR FOR TREATMENT OF SCHIZOPHRENIA, BIPOLAR DISORDER, COGNITIVE DISORDER, AND CLINICAL DEPRESSION 2016
  • Moskal Joseph R.
  • Meltzer Hebert
RU2802972C2
ANTIVIRAL COMPOUNDS 2010
  • Degoj Dehvid A.
  • Khatchins Charl'Z V.
  • Kati Uorren M.
  • Donner Pamela L.
  • Nel'Son Lissa T.
  • Dzhinkerson Tammi K.
  • Keddi Rajan Dzh.
  • Motter Kristofer Eh.
  • Matulenko Mark A.
  • Krjuger Allan K.
  • Patel Sachin V.
  • Randolf Dzhon T.
  • Soltvedel Todd N.
RU2541571C2
TRITERPENE DERIVATIVES OF LUPEOL TYPE AS ANTIVIRAL PREPARATIONS 2010
  • Partkhasaradkhi Reddi Bandi
  • Manokhar Skharma Vedula
  • Ratkhnakar Reddi Kura
  • Madkhanmokhan Reddi Musku
  • Ella Reddi Nelli
  • Vl Subrakhmaniam Lanka
RU2561604C2
3-AMINOPYRROLIDINE DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS 2003
  • Sjueh Chu-Bjao
  • Metkaf Brajan
  • Fehn Khao
  • Tsao Gan'Fehn
  • Khuan Tajshing
  • Chzhehn Chanshehn
  • Robinson Darius Dzh
  • Khan' Ehmi Tsi
RU2355679C2
CYTOTOXIC PEPTIDES AND ANTIBODY-DRUG CONJUGATES THEREOF 2012
  • Doroski Matthew David
  • Maderna Andreas
  • O'Donnell Christopher John
  • Subramanyam Chakrapani
  • Vetelino Beth Cooper
  • Dushin Russell George
  • Strop Pavel
  • Graziani Edmund Idris
RU2586885C2
COMPOUNDS AND COMPOSITIONS USED FOR TREATMENT OF NTRK-RELATED DISORDERS 2016
  • Wenglowsky Steven Mark
  • Brooijmans Natasja
  • Miduturu Chandrasekhar V.
  • Bifulco Neil
RU2744974C2
PYRAZOL-4-YL-HETEROCYCLYL-CARBOXAMIDE COMPOUNDS AND METHODS FOR APPLICATION 2012
  • Khodzhz Alaster Dzh.
  • Matteuchchi Mitsio
  • Sharp Endryu
  • San Minkhua
  • Tsui Viki Kh.
  • Van Syaotszin
RU2638552C2
MELANOCORTIN RECEPTOR AGONISTS 2007
  • Choi Sung Pil
  • Akhn In Ae
  • Li Sang Khjup
  • Li Sang Dae
  • Shin Mi Sook
  • Li Koo
  • Choj Deog Jang
  • Shim Dong Sup
  • Jim Khieon Dzoo
  • Joon Min Kiung
  • Chung Soo Jong
  • Li Dzung Ae
  • Kha Jong Khva
  • Kim Jang Kvan
  • Park Oeuk
  • Li Khiun Min
  • Kim Joun Khoa
RU2411240C2
NEW BIPHENYL COMPOUND OR ITS SALT 2016
  • Yamashita, Satoshi
  • Ogawa, Takahiro
  • Komatani, Hideya
RU2726622C2
COMPOUNDS AND METHODS FOR ENHANCED DEGRADATION OF TARGET PROTEINS AND OTHER POLYPEPTIDES BY AN E3 UBIQUITIN LIGASE 2013
  • Kruz Krejg M.
  • Bakli Dennis
  • Chulli Alessio
  • Jergensen Uillyam
  • Geriss Piter S.
  • Van Molle Inge
  • Gustafson Dzheffri
  • Tkhe Khen-Sop
  • Mishel Zhyulen
  • Khojer Dentin Uejd
  • Rot Anke G.
  • Kharling Dzhon Devid
  • Smit Yan Edvard Devid
  • Miakh Afdzhal Khussejn
  • Kampo Sebastyan Andre
  • Le Zhoell
RU2666530C2

RU 2 621 049 C2

Authors

Kkhan Amin M.

Moskal Dzhozef

Dates

2017-05-31Published

2012-10-24Filed